Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health
CCR - For Our Staff| Home |

Our Science – McKinnon Website

Katherine M. McKinnon

Selected Publications

1)  Moniuszko M, Lipinska D, Jeznach M, Kowal K, Grubczak K, Rusak M, McKinnon K, Vaccari M, Liyanage NP, Fenizia C, Wawrusiewicz-Kurylonek N, Dabrowska M, Jablonska E, Kretowski A, Gorska M, Bodzenta-Lukaszyk A.
Glucocorticoids upregulate decreased IL-7 receptor expression in asthmatic patients and simian immunodeficiency virus-infected non-human primates.
J. Biol. Regul. Homeost. Agents. 27: 427-42, 2013.
2)  Black PL, McKinnon KM, Wooden SL, Ussery MA.
Antiviral activity of biological response modifiers in a murine model of AIDS. Requirement for augmentation of natural killer cell activity and synergy with oral AZT.
Int. J. Immunopharmacol. 18: 633-50, 1996.
3)  Moniuszko M, Liyanage NP, Doster MN, Parks RW, Grubczak K, Lipinska D, McKinnon K, Brown C, Hirsch V, Vaccari M, Gordon S, Pegu P, Fenizia C, Flisiak R, Grzeszczuk A, Dabrowska M, Robert-Guroff M, Silvestri G, Stevenson M, McCune J, Franchini G.
Glucocorticoid Treatment at Moderate Doses of SIVmac251-Infected Rhesus Macaques Decreases the Frequency of Circulating CD14(+)CD16(++) Monocytes But Does Not Alter the Tissue Virus Reservoir.
AIDS Res. Hum. Retroviruses. 2014.
4)  Hirsch D, Barker N, McNeil N, Hu Y, Camps J, McKinnon K, Clevers H, Ried T, Gaiser T.
LGR5 positivity defines stem-like cells in colorectal cancer.
Carcinogenesis. 35: 849-58, 2014.
5)  Richards AJ, Staats J, Enzor J, McKinnon K, Frelinger J, Denny TN, Weinhold KJ, Chan C.
Setting objective thresholds for rare event detection in flow cytometry.
J. Immunol. Methods. 2014.
6)  Sui Y, Hogg A, Wang Y, Frey B, Yu H, Xia Z, Venzon D, McKinnon K, Smedley J, Gathuka M, Klinman D, Keele BF, Langermann S, Liu L, Franchini G, Berzofsky JA.
Vaccine-induced myeloid cell population dampens protective immunity to SIV.
J. Clin. Invest. 124: 2538-49, 2014.
7)  Mesri M, Birse C, Heidbrink J, McKinnon K, Brand E, Bermingham CL, Feild B, Fitzhugh W, He T, Ruben S, Moore PA.
Identification and characterization of angiogenesis targets through proteomic profiling of endothelial cells in human cancer tissues.
PLoS ONE. 8: e78885, 2013.
8)  Vargas-Inchaustegui DA, Xiao P, Hogg AE, Demberg T, McKinnon K, Venzon D, Brocca-Cofano E, Dipasquale J, Lee EM, Hudacik L, Pal R, Sui Y, Berzofsky JA, Liu L, Langermann S, Robert-Guroff M.
Immune targeting of PD-1(hi) expressing cells during and after antiretroviral therapy in SIV-infected rhesus macaques.
Virology. 447: 274-84, 2013.
9)  Demberg T, Brocca-Cofano E, Xiao P, Venzon D, Vargas-Inchaustegui D, Lee EM, Kalisz I, Kalyanaraman VS, Dipasquale J, McKinnon K, Robert-Guroff M.
Dynamics of memory B-cell populations in blood, lymph nodes, and bone marrow during antiretroviral therapy and envelope boosting in simian immunodeficiency virus SIVmac251-infected rhesus macaques.
J. Virol. 86: 12591-604, 2012.
10)  Zhao J, Stagno JR, Varticovski L, Nimako E, Rishi V, McKinnon K, Akee R, Shoemaker RH, Ji X, Vinson C.
P6981, an Arylstibonic Acid, is a Novel Low Nanomolar Inhibitor of CREB binding to DNA.
Mol Pharmacol. 82: 814-23, 2012.
11)  Patterson LJ, Kuate S, Daltabuit-Test M, Li Q, Xiao P, McKinnon K, DiPasquale J, Cristillo A, Venzon D, Haase A, Robert-Guroff M.
Replicating adenovirus-simian immunodeficiency virus (SIV) vectors efficiently prime SIV-specific systemic and mucosal immune responses by targeting myeloid dendritic cells and persisting in rectal macrophages, regardless of immunization route.
Clin. Vaccine Immunol. 19: 629-37, 2012.
12)  Lee CN, Heidbrink JL, McKinnon K, Bushman V, Olsen H, Fitzhugh W, Li A, Van Orden K, He T, Ruben SM, Moore PA.
RNA Interference Characterization of Proteins Discovered by Proteomic Analysis of Pancreatic Cancer Reveals Function in Cell Growth and Survival.
Pancreas. 41: 84-94, 2012.
13)  Edwards DC, McKinnon KM, Fenizia C, Jung KJ, Brady JN, Pise-Masison CA.
Inhibition of geranylgeranyl transferase-I decreases cell viability of HTLV-1-transformed cells.
Viruses. 3: 1815-35, 2011.
14)  Demberg T, Ettinger AC, Aladi S, McKinnon K, Kuddo T, Venzon D, Patterson LJ, Phillips TM, Robert-Guroff M.
Strong viremia control in vaccinated macaques does not prevent gradual Th17 cell loss from central memory.
Vaccine. 29: 6017-28, 2011.
15)  Brocca-Cofano E, McKinnon K, Demberg T, Venzon D, Hidajat R, Xiao P, Daltabuit-Test M, Patterson LJ, Robert-Guroff M.
Vaccine-elicited SIV and HIV envelope-specific IgA and IgG memory B cells in rhesus macaque peripheral blood correlate with functional antibody responses and reduced viremia.
Vaccine. 29: 3310-9, 2011.
16)  Fang DD, Kim YJ, Lee CN, Aggarwal S, McKinnon K, Mesmer D, Norton J, Birse CE, He T, Ruben SM, Moore PA.
Expansion of CD133(+) colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery.
Br. J. Cancer. 102: 1265-75, 2010.
17)  Weaver JL, McKinnon K, Germolec DR.
Phenotypic analysis using very small volumes of blood.
Curr Protoc Cytom. Chapter 6: Unit 6.30, 2010.
18)  Weaver JL, Broud DD, McKinnon K, Germolec DR.
Serial phenotypic analysis of mouse peripheral blood leukocytes.
Toxicol. Mech. Methods. 12: 95-118, 2002.
19)  Rosenberg YJ, Cafaro A, Brennan T, Greenhouse JG, McKinnon K, Bellah S, Yalley-Ogunro J, Gartner S, Lewis MG.
Characteristics of the CD8+ lymphocytosis during primary simian immunodeficiency virus infections.
AIDS. 11: 959-68, 1997.
20)  Rosenberg YJ, Cafaro A, Brennan T, Greenhouse JG, Villinger F, Ansari AA, Brown C, McKinnon K, Bellah S, Yalley-Ogunro J, Elkins WR, Gartner S, Lewis MG.
Virus-induced cytokines regulate circulating lymphocyte levels during primary SIV infections.
Int. Immunol. 9: 703-12, 1997.
21)  Lewis MG, Bellah S, McKinnon K, Yalley-Ogunro J, Zack PM, Elkins WR, Desrosiers RC, Eddy GA.
Titration and characterization of two rhesus-derived SIVmac challenge stocks.
AIDS Res. Hum. Retroviruses. 10: 213-20, 1994.
22)  Black PL, McKinnon KM, Wooden SL, Ussery MA.
Antiviral activity of a synthetic double-stranded polyribonucleotide interferon inducer in a murine AIDS retrovirus model. Role of augmentation of natural killer cell activity and synergy with oral AZT.
Ann. N. Y. Acad. Sci. 685: 467-70, 1993.
Click Here to View Collapsed Bibliography.

This page was last updated on 8/5/2014.